These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 25545966)

  • 1. Protective effect of a germline, IL-17-neutralizing antibody in murine models of autoimmune inflammatory disease.
    Dallenbach K; Maurer P; Röhn T; Zabel F; Kopf M; Bachmann MF
    Eur J Immunol; 2015 Apr; 45(4):1238-47. PubMed ID: 25545966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis.
    Röhn TA; Jennings GT; Hernandez M; Grest P; Beck M; Zou Y; Kopf M; Bachmann MF
    Eur J Immunol; 2006 Nov; 36(11):2857-67. PubMed ID: 17048275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effects of interleukin-1β and interleukin-17A antibodies on collagen-induced arthritis mouse model.
    Zhang Y; Ren G; Guo M; Ye X; Zhao J; Xu L; Qi J; Kan F; Liu M; Li D
    Int Immunopharmacol; 2013 Feb; 15(2):199-205. PubMed ID: 23280345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of rat autoimmune disease by a monoclonal antibody specific for T lymphoblasts.
    Schluesener H; Brunner C; Vass K; Lassmann H
    J Immunol; 1986 Dec; 137(12):3814-20. PubMed ID: 3491149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active immunization with IL-1 displayed on virus-like particles protects from autoimmune arthritis.
    Spohn G; Keller I; Beck M; Grest P; Jennings GT; Bachmann MF
    Eur J Immunol; 2008 Mar; 38(3):877-87. PubMed ID: 18253928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL13 antibody for the treatment of autoimmune disorders.
    Klimatcheva E; Pandina T; Reilly C; Torno S; Bussler H; Scrivens M; Jonason A; Mallow C; Doherty M; Paris M; Smith ES; Zauderer M
    BMC Immunol; 2015 Feb; 16(1):6. PubMed ID: 25879435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active immunization against IL-23p19 improves experimental arthritis.
    Ratsimandresy RA; Duvallet E; Assier E; Semerano L; Delavallée L; Bessis N; Zagury JF; Boissier MC
    Vaccine; 2011 Nov; 29(50):9329-36. PubMed ID: 22008816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
    Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
    Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mining the human autoantibody repertoire: isolation of potent IL17A-neutralizing monoclonal antibodies from a patient with thymoma.
    Beerli RR; Bauer M; Fritzer A; Rosen LB; Buser RB; Hanner M; Maudrich M; Nebenfuehr M; Toepfer JA; Mangold S; Bauer A; Holland SM; Browne SK; Meinke A
    MAbs; 2014; 6(6):1608-20. PubMed ID: 25484038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-IL-17A autovaccination prevents clinical and histological manifestations of experimental autoimmune encephalomyelitis.
    Uyttenhove C; Sommereyns C; Théate I; Michiels T; Van Snick J
    Ann N Y Acad Sci; 2007 Sep; 1110():330-6. PubMed ID: 17911448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel human anti-interleukin-1β neutralizing monoclonal antibody showing in vivo efficacy.
    Goh AX; Bertin-Maghit S; Ping Yeo S; Ho AW; Derks H; Mortellaro A; Wang CI
    MAbs; 2014; 6(3):765-73. PubMed ID: 24671001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of anti-interleukin-17A aptamer: suppression of interleukin-17A signaling and attenuation of autoimmunity in two mouse models.
    Ishiguro A; Akiyama T; Adachi H; Inoue J; Nakamura Y
    Arthritis Rheum; 2011 Feb; 63(2):455-66. PubMed ID: 20967861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis.
    Hueber W; Patel DD; Dryja T; Wright AM; Koroleva I; Bruin G; Antoni C; Draelos Z; Gold MH; ; Durez P; Tak PP; Gomez-Reino JJ; ; Foster CS; Kim RY; Samson CM; Falk NS; Chu DS; Callanan D; Nguyen QD; ; Rose K; Haider A; Di Padova F
    Sci Transl Med; 2010 Oct; 2(52):52ra72. PubMed ID: 20926833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric anti-IL-17 full-length monoclonal antibody is a novel potential candidate for the treatment of rheumatoid arthritis.
    Bai F; Tian H; Niu Z; Liu M; Ren G; Yu Y; Sun T; Li S; Li D
    Int J Mol Med; 2014 Mar; 33(3):711-21. PubMed ID: 24378614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with IL-6 analogues induces autoantibodies to IL-6 and influences experimentally induced inflammation.
    Galle P; Jensen L; Andersson C; Cuzzocrea S; Di Paola R; Nicoletti F; Svenson M; Bendtzen K; Thomsen AR; Hansen MB
    Int Immunopharmacol; 2007 Dec; 7(13):1704-13. PubMed ID: 17996680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical development of GR1501, a human monoclonal antibody that neutralizes interleukin-17A.
    Shan Y; Shi K; Qian X; Chang Z; Yang J; Gao Y; Jin W; Luo Q; Xu Q
    Biochem Biophys Res Commun; 2019 Sep; 517(2):303-309. PubMed ID: 31353088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An antibody to IP-10 is a potent antagonist of cell migration in vitro and in vivo and does not affect disease in several animal models of inflammation.
    Byrne FR; Winters A; Brankow D; Hu S; Juan T; Steavenson S; Doellgast G; Kuchimanchi K; Brown H; Anderson S; Smelt S; Sullivan T; Alcorn D; Tocker J; Dean C; Macmaster J; Kirchner J; Buys J; Manoukian R; Jiao E; Zou X; Campanella GS; Siu G
    Autoimmunity; 2009 Mar; 42(3):171-82. PubMed ID: 19301198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual Inhibition of Interleukin-23 and Interleukin-17 Offers Superior Efficacy in Mouse Models of Autoimmunity.
    Mangan PR; Su LJ; Jenny V; Tatum AL; Picarillo C; Skala S; Ditto N; Lin Z; Yang X; Cotter PZ; Shuster DJ; Song Y; Borowski V; Thomas RL; Heimrich EM; Devaux B; Das Gupta R; Carvajal I; McIntyre KW; Xie J; Zhao Q; Struthers M; Salter-Cid LM
    J Pharmacol Exp Ther; 2015 Aug; 354(2):152-65. PubMed ID: 26015463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.